Patient and parent perceptions of the diagnosis and management of cystic fibrosis-related diabetes  by Millington, Kate et al.
Contents lists available at ScienceDirect
Journal of Clinical & Translational Endocrinology
journal homepage: www.elsevier .com/locate/ jcte
Journal of Clinical & Translational Endocrinology 1 (2014) 100e107Research PaperPatient and parent perceptions of the diagnosis and management
of cystic ﬁbrosis-related diabetesq
Kate Millington a, Victoria Miller b, Ronald C. Rubenstein c, Andrea Kelly d,*
a Perelman School of Medicine, University of Pennsylvania, 100 Stemmler Hall, Philadelphia, PA 19104, USA
bDivision of Adolescent Medicine, The Children’s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine at the University of
Pennsylvania, Philadelphia, PA 19104, USA
cDivision of Pulmonary Medicine and Cystic Fibrosis Center, The Children’s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine
at the University of Pennsylvania, Philadelphia, PA 19104, USA
dDivision of Endocrinology & Diabetes, The Children’s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine at University of
Pennsylvania, Philadelphia, PA 19104, USAa r t i c l e i n f o
Article history:
Received 20 May 2014
Received in revised form
30 June 2014
Accepted 3 July 2014
Keywords:
Cystic ﬁbrosis
Diabetes
Adherenceq This is an open access article under the CC
creativecommons.org/licenses/by-nc-nd/3.0/).
This work was supported by the Cystic Fibrosis Fo
[grant number = “MILLIN13A0”] and the Cystic Fibros
UPenn CF Care Center, RCR).
* Corresponding author. Division of Endocrinology &
of Philadelphia, 34th Street, Civic Center Blvd., Philade
215 5903174.
E-mail address: kellya@email.chop.edu (A. Kelly).
2214-6237/$ e see front matter  2014 The Authors.
http://dx.doi.org/10.1016/j.jcte.2014.07.003a b s t r a c t
Background: Cystic Fibrosis Related Diabetes (CFRD) is an increasingly common complication in CF. CFRD
introduces an additional complex chronic disease to individuals already attending to demanding treat-
ment regimens. An improved understanding of the reaction to and coping mechanisms surrounding
CFRD may facilitate management of CFRD.
Methods: Semi-structured interviews completed by 10 children with CFRD, 10 adults with CFRD and 10
parents of children with CFRD in a single large CF Care Center were analyzed utilizing phenomenological
analysis.
Results: Patients and families reported having limited knowledge of CFRD prior to diagnosis. CFRD was
considered an extension of their underlying CF and successful management depended upon integration
into existing routines.
Conclusions: Health care professionals caring for patients with CFRD should be informed of the speciﬁc
challenges that arise in CFRD. Education in advance of CFRD diagnosis may facilitate management.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Introduction
Cystic Fibrosis Related Diabetes (CFRD) is a common comorbidity
affecting people with cystic ﬁbrosis (CF). CFRD becomes increasingly
prevalentwith increasing agewith an estimated prevalence of 50% in
CF patients aged 30 years and greater [1e3]. As management of CF
continues to advance, the proportion of patients with CF related co-
morbidities such as CFRD is expected to increase. Untreated CFRD is
associated with worse pulmonary function, increased pulmonary
exacerbation frequency, and decreased survival, while aggressive
treatment of CFRD is associated with improved outcomes [4,5].BY-NC-ND license (http://
undation Therapeutics (KM)
is Foundation CC015 (CHOP/
Diabetes, Children’s Hospital
lphia, PA 19104, USA. Tel.: þ1
Published by Elsevier Inc. All rightThe diagnosis of CFRD in people with CF represents the intro-
duction of an additional chronic disease and signiﬁcant additional
medical burden: blood glucose monitoring, subcutaneous insulin
injections and risk of hypoglycemia, attention to diet and nutrition,
and additional medical appointments. The literature describing
reactions and the perceived barriers to management of CFRD is
limited. In previous reports, adolescents and adults recollected
feelings of shock, anxiety, and relief upon the diagnosis of CFRD as
well as maladaptive behaviors surrounding management re-
quirements [6]. Some viewed their diabetes as an extension of CF,
others saw CFRD as a nuisance that could be ignored when the
primary challenges of CF escalated, while still others felt that having
lived with CF made them better equipped to address diabetes
management [7]. These data also revealed that most CF patients
were unfamiliar with the possibility of developing diabetes and that
many lacked the knowledge and conﬁdence to approach this new
chronic illness [6e8].
Existing reports include few participants diagnosed with CFRD
as children [6], and to our knowledge there have been no studies
of how children react to CFRD management. Available data ons reserved.
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focused on adolescent autonomy [8]. We know very little about
the ways in which patients and parents manage CFRD and factors
that make adherence more or less difﬁcult. Data related to such
issues will help providers identify targets of intervention to
improve adjustment and adherence, at diagnosis and over time. As
such, the aim of the present study was to examine the reactions of
children and adolescents, their parents, and adults with CF to
CFRD management and factors that facilitate or impede treatment
adherence.
Methods
Design
A cross-sectional, mixed-methods, descriptive study design was
used. Single occasion qualitative interviewswere utilized to explore
participants’ reactions to the diagnosis of CFRD and daily experi-
ence with the disease. The Institutional Review Board of the Chil-
dren’s Hospital of Philadelphia approved the study, and all subjects
provided informed consent and assent as appropriate.
Participants
A convenience sample of children and adolescents with CFRD
and their parents as well as adults were recruited from the Cystic
Fibrosis Center and the Endocrinology clinic of the Children’s
Hospital of Philadelphia and the Adult CF Program at the Hospital
of the University of Pennsylvania, which are tertiary care hospi-
tals in the Northeastern United States. Adult, adolescent, and
child patient participants were included if they had a diagnosis of
CFRD according to accepted guidelines [9], were older than age 8
years, and spoke English. The peak age of onset of CFRD is typi-
cally in late adolescence to early adulthood and is rare in patients
younger than 8 years [3,10]. Thus, including only patients greater
than 8 years improved the quality of the interviews without
compromising eligible participant inclusion. A child with CFRD
and his/her parent(s) could both participate. Participants were
excluded for mental or developmental disorders, health status, or
functional impairment that would prevent completion of in-
terviews. However, parents of such children were eligible. Two
potential subjects declined to participate: one adult with CFRD
and one parent completed the initial consent process and ques-
tionnaires, but did not complete the interview and were not
included in the study sample. We used the standard of thematic
saturation to determine the ﬁnal sample size. In other words, we
stopped interviewing when we determined that no new themes
were emerging from the data [11].
Data collection
Semi-structured individual interviews were conducted with
patients and parents by one interviewer (KM). Interview topics
included the subject’s initial reaction to being diagnosed or to their
child’s diagnosis with CFRD, their overall attitude toward CF and
CFRD management, the impact of CFRD on daily life, and the
methods used to cope with the daily care of CF and CFRD (see
Online Supplement). Interviews were digitally recorded and tran-
scribed verbatim. For descriptive purposes, the Cystic Fibrosis
Questionnaire-Revised (CFQ-R) was used to measure each subject’s
health related quality of life. The CFQ-R yields a standardized scale
ranging from 0 to 100, with higher scores reﬂecting better quality of
life [12,13]. For participants with CF and the children of parent
participants, clinical variables including FEV1, BMI, and HbA1c, werecollected from the electronic medical record to characterize CF
disease severity and CFRD control.
Analysis
Descriptive data were presented as mean with standard devia-
tion and minimum and maximum if continuous or as percentages
for categorical data. Visual inspection of scatterplots examining the
relationship of HbA1C with CFQ-R subscales was undertaken, and
pairwise correlations were performed. Two members of the study
team (K.M. and V.M.) independently read two transcripts and
generated ideas for an initial coding structure, and then discussed
these ideas to ﬁnalize the coding structure [14]. Interview tran-
scripts were then coded by the ﬁrst author for major themes and
sub-themes. Initially coding labels were applied to units of meaning
within the transcribed text. Participants’ comments and percep-
tions were sorted, aggregated, and synthesized [15]. Adult and child
participant responses were analyzed together as these groups were
sharing ﬁrst person reactions. Parent responses were analyzed
separately. Quotes were selected to illustrate key themes from the
analysis (Table 1).
Results
Participants
Ten children and adolescents, ten adults and ten parents
participated in the study. Nine of the child participants and one of
the adult participants had a parent who participated in the study.
Two of the adult participants had undergone lung transplantation.
One parent whose child had both CFRD and severe autism partici-
pated, but the child was unable to participate due to developmental
issues. Semi-structured individual interviews were conducted with
participants either in conjunction with a previously scheduled
clinic visit (n ¼ 19), during an inpatient stay (n ¼ 7), or over the
phone (n ¼ 4). One child participant and three adult participants
utilized an insulin pump. Demographic data, clinical characteristics,
and CFQ-R subscale results for the sample are portrayed in Table 2.
No relationships between CFQ-R subscales and current HbA1Cwere
identiﬁed (Figure 1).
Prior knowledge of diabetes
Expectations and preparation prior to the diagnosis of CFRD
varied widely. Many patients and parents (4/10 children, 5/10
adults, and 3/10 parents) reported having prior experience with
diabetes from friends, family members, or acquaintances they knew
with Type 1 or Type 2 diabetes. Knowledge about diabetes varied
from knowing only that diabetes had to do with blood sugar to an
understanding of complications including amputations, organ
damage, neuropathy, and blindness. Five patients anticipated that
with diabetes they would have to change their diet. Assumptions
that one got diabetes from “not taking care of themselves” were
brought up by 2 adults and 1 child.
Half of the participants were aware that diabetes as a result of CF
was possible. Three parents had heard about CFRD from attending
‘CF Education Nights.’ Two parents knew other CF patients who had
developed CFRD. Many parents recalled hearing about CFRD when
their children were ﬁrst diagnosed with CF.
Annual screening for CFRD helped some (3/10 children and 3/10
parents) ‘warm up’ to the possibility of being diagnosed with CFRD
and to accept the diagnosis when it did come. One adult patient
whowas diagnosed prior to the initiation of CFRD screening wished
that more screening had been done prior to his diagnosis.
Table 1
Illustrative quotes
Prior knowledge of diabetes “I’ll never forget going to the meeting [CF Education Night] and talking about this CF related diabetes and we’re like, ‘Oh
no, what is that now?’ It was scary to hear about that just going through the years. I wasn’t happy to hear about that. I
thought we would never have to worry about it.” (P11)a
“You know about Type I and Type II and you look at some the people that have it and you’re like, ‘Whoa, that’s not going
to be me.’” (A3)
Reactions to
CFRD management
“At ﬁrst I thought it was going to, like, be really really hard and I wouldn’t knowwhat to do at ﬁrst, but then as timewent
by I got the feel for it and its becoming a part of my every day routine and just something I do every day now.” (C5)
“Because you already had a new normal. You got your new normal when he was diagnosed. So anything that came with
that is all a part of the new normal because it’s all related to that one thing.” (P1)
“I have more to do, like, more treatments, nebulizers, and enzymes. I have to worry about all that. All I have to do with
my diabetes is give myself insulin and check my sugar and that’s all” (C4)
“I saw it as something that would hamper my lifestyle. Something that would, you know, interfere. for the most part
until then I just had to worry about taking some enzymes maybe an antibiotic. During the day it didn’t really impact me
. other than a few little things here or there I was living ‘a normal life.’ So, that was kind of a major hurdle major for
me.” (A5)
Barriers to CFRD
treatment adherence
“Before I go to bed I’m just super tired and I just want to go to bed and I don’t want to check my sugar and I forget about
it. In the morning I’m super busy, especially when I get up for school, and I have a lot of things to do and I’ll be running
out the door and I’ll forget my sugar.” (C4)
“I think, like, if I get really stressed and overwhelmedwith everything, like, with CF and school and everything I’ll kind of
not do it. Because I’m just, like, overwhelmed and I don’t want to do it.” (C7)
“[Prandin] didn’t really do anything, anything that I could see. So you couldn’t really see any change then it didn’t do shit
was the way I saw it.” (A8)
“Remembering to test blood sugar can often be a task that’s not easy to accomplish. but that’s not so huge in the actual
care of the thing itself. Especially if you know that you have a good insulin regimen going and there’s no real reason that
you should be high at any point.” (C6)
Factors promoting
CFRD treatment adherence
“I got an ulcer onmy arm. and I was like, ‘I’mnot going to have these all over my body, absolutely not.’ I’m very vain so
I pride myself in my looks. I’m not going to walk around with ulcers on my body or lose my feet or my ﬁngers. That’s not
going to happen to me because there’s too much that I have planned for myself.” (A7)
“They really told me that you need to start really taking an aggressive stance on this. As soon as they told me it could
affect lung function that’s when I really started listening, ‘Yeah, this needs to change.’” (A3)
“A schedule that works, which is hard to develop. But if you can get a schedule that works it’s much easier, because
sticking to that schedule is a lot easier than sort of having to juggle it on a day to day basis assessing each situation as it
comes.”(C6)
Patient responsibility
for CFRD management
“He decided that he was going to take [CFRD] on as one of his responsibilities. So that’s. he does it. and I think he’s
more comfortable doing it. Sometimes I think he does it because he knows it bothers me to do it so he takes that on
himself.” (P1)
“It was more or less that she didn’t want me in her space. Coming up and sticking her here and doing that. You know
what I mean? She’s a young teenager going through, you know, changes. So, it’s kind of like, “You’re in my space and I
don’t.” That’s one of the reasons too that she has taken full control, I think, of doing it.” (P3)
Role of the health care team “Anytime I need anything, you know, a call or a text or an email away. They really help me, they support
me that way.” (A5)
a A ¼ adult participant, C ¼ child participant, P ¼ parent participant.
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The addition of “one more thing” to their existing CF routine and
maintenance was the most frustrating aspect of the diagnosis (6/10
children, 6/10 adults, and 6/10 parents) due to the addition of
medications, time, and the understanding of new potential
complications.
Many patients and parents felt that having CF prepared them to
face a diagnosis of CFRD. They were already acclimated to a routine
of medications, treatments, clinic visits, and hospitalizations and
were able to easily incorporate CFRD into the existing structure of
CF (4/10 children, 4/10 adults, and 6/10 parents). In fact, the diag-
nosis of CFRD was sometimes downplayed because the addition of
management of CFRD was small compared to the complex regimen
for CF (2/10 children, 3/10 adults, and 2/10 parents).
Many patients (7/10 children and 4/10 adults) were upset
because they didn’t want to receive injections. For adults more than
children (1/10 child and 7/10 adults), the diagnosis of diabetes was
distressing because it was an interruption to the ‘normal’ routine
they had developed with their CF.
Potential or realized changes in diet were distressing for patients
and parents. The belief that one had to change one’s diet when
diagnosed with CFRD was split; more adults with CFRD believed
they did have to watch their diet (1/10 children, 7/10 adults, and 3/
10 parents), while a greater proportion of children with CFRDbelieving that their CF diet took precedence (5/10 children, 2/10
adults, and 3/10 parents).Factors impeding CFRD treatment adherence
Table 3 illustrates key themes related to CFRD treatment
adherence. The most commonly cited reason for non-adherence to
the treatment regimen for CFRD was forgetting either insulin in-
jections or, more commonly, blood sugar measurements (9/10
children and 6/10 adults). Remembering was especially difﬁcult
when patients were hungry, not at home, or under other time de-
mands (3/10 children and 4/10 adults). The second most common
reason for non-adherence was avoidance of the pain from insulin
injections or blood sugar testing (6/10 children and 3/10 adults). A
recurring theme in patient interviews was the embarrassment pa-
tients faced when having to administer insulin injections in public
(1/10 children and 4/10 adults). To avoid embarrassment patients
did injections in the car or a restroom.
The interaction between CF and CFRD was problematic. Specif-
ically, CFRD was difﬁcult to care for when patients were suffering
from a pulmonary exacerbation both because it was more difﬁcult
to attend to their care in general while ill, but also because medi-
cations (i.e. corticosteroids) utilized for CF made controlling their
blood sugars challenging (3/10 children and 3/10 adults). The lack of
Table 2
Demographic and clinical characteristics of participants
Child participants
(N ¼ 10)
Adult participants
(N ¼ 10)
Parent Participantsa
(N ¼ 10)
Female, % (N) 30% (3) 30% (3) 80% (8)
White, % (N) 90% (9) 90% (9) 90% (9)
Age, years; mean (SD),
minemax
14.6 (2.2) 29.5 (9.6) 47.6 (9.1)
10e17 19e48 37e64
Age of child, years; mean (SD),
minemax
e e 14.6 (2.1)
10e17
Married; % (N) e 30% (3) 70% (7)
Household income; % (N)
< $20,000 e 40% (4) 10% (1)
$20,001e$60,000 e 10% (1) 20% (2)
$60,001e$100,000 e 10% (1) 40% (4)
>$100,000 e 30% (3) 30% (3)
Age of patientb at CFRD diagnosis, years; mean (SD),
minemax
12.5 (2.1) 19.9 (8.5) 12.7 (2.1)
10e15 9e35 10e15
Duration of patient’s CFRD diagnosis, years; mean (SD),
minemax
2.2 (1.5) 9.6 (4.3) 2.0 (1.6)
0e4 4e18 0e4
Patient BMI; mean (SD),
minemax
20.4 (2.9) 23.5 (1.7) 20.1 (2.9)
16.0e25.8 20.6e25.5 16.0e25.8
Patient HbA1c; mean (SD),
minemax
5.7 (0.6) 8.0 (1.7) 5.7 (0.6)
4.8e6.7 6.2e10.1 4.8e6.7
Patient FEV1 % of predicted value; mean (SD),
minemax
83.4 (25.9) 67.1 (27.4) 83.4 (25.9)
38e113 43e130 38e113
Patient FVC % of predicted value; mean (SD),
minemax
93.2 (20.3) 75.3 (24.5) 93.2 (20.3)
53e115 47e125 53e115
CFQ-R scorec; mean (SD)
Scalesd:
Physical 75.7 (20.9) 74.1 (28.9) 76.2 (23)
Emotion 70.1 (21.3) 73.3 (12.9) 69.2 (12.4)
Body image 58.9 (30.6) 78.9 (21.9) 61.1 (21.5)
Eating 73.3 (32.8) 97.8 (4.7) 70 (37.5)
Treatment burden 54.4 (17.1) 58.3 (22.1) 41.7 (30.7)
Respiratory 60.2 (27.3) 72.9 (5.5) 71 (17.2)
Digestive 74.4 (30.1) 86.7 (20.2) 61.1 (17.2)
a One parent participant had a child (not included as a child participant) with severe autism.
b For parent participants, “patient” data refer to their children with CFRD.
c Parent participants reported on their children’s quality of life.
d Combined scores for CFQ-child (age < 14y, n ¼ 3) and CFQ-teen/adult (age  14y, n ¼ 7) were combined for the “child” participants.
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patients (1/10 children and 2/10 adults).
Four patients rationalized the omission of blood sugar testing or
insulin injections by saying that they snack all day so the blood
reading wouldn’t be accurate, that they didn’t need to give insulin
to lower a high blood sugar because they could ‘work it off,’ or that
estimating the amount of insulin they needed without checking
their blood sugar was ‘good enough.’ Two patients felt that as long
as they were adherent with their insulin blood sugar monitoring
was more ‘ﬂexible.’
For parents, barriers to their children completing CFRD main-
tenance tasks were due to time constraints, pain avoidance, and
child resistance. Although not as time consuming as CF treatments,
parents were frustrated by having to remind their children to check
blood sugars and do insulin injections especially when trying to
work around activities, school, and family events (3/10 parents).
Those who were injecting their children with insulin found having
to inﬂict pain on their child troublesome (5/10 parents). Child
resistance to treatments, especially in the adolescent age group,
was a challenge (3/10 parents).
Factors promoting CFRD treatment adherence
Incorporating CFRD into the daily routine was the most
commonly cited strategy for adherence (6/10 children, 4/10 adults,
and 1/10 parents).
Patients were strongly motivated to take care of their CFRD by
either the occurrence of an adverse event attributable to their CFRDor by the possibility of increased morbidity and mortality in the
future (2/10 children and 3/10 adults). One patient noted that he
was consistent with his insulin, while being non-adherent with
other CF treatments, because since starting insulin he had been
hospitalized less frequently. Another patient was motivated to take
better control of his blood sugar in order to participate in a clinical
trial for a CF medication. Two patients tried to be successful in
managing their CFRD to avoid disappointing their parents or the
health care team. Having parents remind them or prepare treat-
ments was helpful for ﬁve patients. Improvement in lung function
associated with better diabetes control was motivating for patients
(1/10 children and 5/10 adults).
School nurse supervision of injections and blood glucose checks
during the day was useful for parents to assure adherence. Parents
also felt that being vigilant about organizing medications and
supplies was critical to guaranteeing adherence.
Patient responsibility for CFRD management
Although many patients were still working on becoming inde-
pendent with CF treatments they were able to manage diabetes on
their own (9/10 children). One child who was completely depen-
dent on her parents for both CF and CFRD care was also the youn-
gest in our sample (10 years). All of the child participants reported
that they were able to manage high and low blood glucose inde-
pendently. CFRD carewas seen as simpler than CFmanagement and
also required management when parents may not be present (e.g.,
managing hyper- or hypoglycemia). One parent felt that her child
Figure 1. HbA1C and Quality of Life in CFRD. No relationships between HbA1C and various CFQ-R subscales were observed in children with CFRD (B), their parents (C), and adults
with CFRD ().
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Table 3
Factors impeding and facilitating CFRD treatment adherence
Factors impeding CFRD treatment adherence Factors promoting CFRD treatment adherence
1. Competing priorities (9/10 children, 6/10 adults) 1. Incorporating CFRD into existing routines (5/10 children, 3/10 adults, 6/10
parents)
2. Interference between CF and CFRD (3/10 children, 3/10 adults) 2. Fear of increased morbidity or mortality (2/10 children, 3/10 adults)
3. Embarrassment completing treatments in public (1/10 children, 4/10 adults) 3. Experiencing an adverse event (1/10 adults)
4. Avoidance Of pain (6/10 children, 3/10 adults) 4. Seeing positive effects from treatment (i.e. improved lung function) (1/10
children, 5/10 adults)
5. Not seeing effects of treatment (1/10 children, 2/10 adults) 5. Avoiding disappointment of parents or providers (1/10 children, 1/10 adults)
6. Minimizing importance of glucose testing (4/10 children, 4/10 adults) 6. Support or supervision of parents or other adults (5/10 children)
7. Child resistance (3/10 parents) 7. Organization of medications and supplies (1/10 parents)
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give her insulin injections was an invasion of personal space.Role of the health care team
Accessibility of the health care team was imperative for most
patients. Patients valued that their health care team not only
recognized how important it was for the CFRD regimen to ﬁt into
their lives, but also helped them come up with strategies to inte-
grate it. It was important to ﬁnd physicians who were knowl-
edgeable about both CF and diabetes (3/10 adults and 1/10 parents).Discussion
The diagnosis of CFRD represents the introduction of an addi-
tional chronic illness to patients and families already dealing with a
demanding and complex treatment regimen. Patients are often
diagnosed during adolescence and adulthood, after they have
assimilated CF into their lives and established a care routine [3].
Adolescence is an especially tumultuous time for those with
chronic disease, and patients may struggle with completing treat-
ment recommendations in the face of social pressures and the
desire for autonomy [16e18]. Little is known about how patients
and their families cope with CFRD diagnosis and management and
how they eventually become successful in dealing with two chronic
diseases.
Many adolescent patients were able to care for their CFRD
independently, and interestingly took on this responsibility before
they were independent with their usual CF care. Unlike inhaled
treatments and airway clearance that are typically done twice daily,
insulin injections and blood sugar monitoring needs to be done
several times throughout the day and often at times when parents
may not be present. For adolescents going through physical changes
and establishing autonomy, having their parents physically inject
them was prohibitive to sharing CFRD responsibility. Many parents
found that dealing with CFRD was a good introduction to the child
taking on more responsibility for their health including CF. If ado-
lescents can ﬁnd success in managing CFRD they may be encour-
aged to take on more CF care as well.
Even for those patients who successfully integrated CFRD care
into their routine, blood glucose testing was often minimized. Pa-
tients felt that blood glucose testing was optional once an insulin
routine had been established. This attitude may contribute to a
failure to respond appropriately to changes in glucose tolerance
that arise with acute illness or changes in medications (e.g., corti-
costeroid use). Practitioners should be aware of this potential pitfall
and focus education on the importance of continued blood glucose
testing.
Dietary guidelines for CFRD are well established. However,
concern was expressed regarding the dietary implications of CFRD
among participants in our study [9]. This issue tended to be moreproblematic for adults which may reﬂect education in the era prior
to involvement of teams specialized in CFRD. Because of the strong
emphasis placed onmaintaining nutrition in patients with CF, often
with a diet of high caloric intake that directly contradicts recom-
mendations for those with Type I or Type II diabetes, practitioners
should focus on dietarymanagement and help patients and families
to develop a nutrition plan that is consistent with current guide-
lines for CFRD. Implementation of consistent approaches to nutri-
tion across the subspecialists caring for individuals with CF may
alleviate this concern.
Our ﬁndings suggest that, for some patients, the diagnosis of
CFRD signiﬁes a major disruption to their ‘normal life.’ While CF
care can often be conﬁned to the home, diabetes care often must
occur in public, which can be awkward for patients [19]. Suddenly
having to deal with health maintenance tasks in public disrupts the
‘normal’ identity that patients had developed. Barriers to and fa-
cilitators of CFRD treatment adherence that we identiﬁed in this
study are similar towhat has been found in prior research related to
adherence to the CF treatment regimen [20e22]. Not surprisingly,
adhering to both the CF and CFRD regimen could be challenging; for
example, completing CFRD tasks could be difﬁcult during a pul-
monary exacerbation, and some participants reported that certain
CF medications interfered with blood glucose control. Given that
regimen complexity and treatment burden have been associated
with decreased adherence in prior research [21e23], the addition of
CFRD management is a risk factor for compromised adherence to
both regimens.
Consistent with prior work, only 50% of our participants were
familiar with the possibility of acquiring CFRD prior to the diagnosis
[6]. Additional challenges include misinformation or assumptions
regarding diabetes, such as the belief that it resulted from not
taking care of oneself and confusion about dietary changes. Annual
CFRD screening was useful for patients to ‘warm them up’ to the
possibility of CFRD [9]. This screening requirement should be an
opportunity for education and preparation rather than simply
another test that patients must complete. This preparation may
decrease patient confusion and distress if they are eventually
diagnosed with CFRD. The support of an accessible and knowl-
edgeable health care team consisting of specialists in CFRD was
perceived as instrumental for most study participants. As the issues
that arise in CFRD are unique and distinct from those of Type I and
Type II diabetes, many participants valued having access to health
care practitioners who speciﬁcally understand the challenges and
management of CFRD.Limitations
This relatively small convenience sample may not represent the
views of all patients and families with CFRD. All participants were
seen at a large, urban, academic, tertiary care center. However,
unlike quantitative research, in which the goal is to make statistical
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the goal of qualitative research is to explore themes and assess the
diversity of experiences that participants have with the phenom-
enon of interest [11,24]. Additionally, those who choose to partici-
pate in qualitative research may have different experiences than
those who are not willing or available to participate. Some bias may
have been introduced by having one author doing all the in-
terviews, coding, and data analysis.
The lack of relationship between quality of life, including
treatment burden, and HbA1C may arise for a variety of reasons.
First, this study was not powered to examine this relationship.
Additionally, an individual with CF may arrive at what is considered
a very good HbA1C, particularly in the absence of fasting hyper-
glycemia, without signiﬁcant effort; while individuals with more
severe insulin deﬁciency will require more intense management.
These issues are not easily represented by either duration of CFRD,
total daily insulin dose (which will often reﬂect the large amount of
calories consumed in CF), or even insulin pump use.
Conclusion
Although patients with CF and their families are experienced
with chronic illness, the addition of a second illness, CFRD, may
represent a signiﬁcant disruption. Health care professionals caring
for these patients should be informed of the speciﬁc challenges that
arise with CFRD and educate patients at diagnosis on potential
complications and recommendations. CFRD speciﬁc dietary rec-
ommendations should be highlighted, as diet continues to be a
focus of confusion and distress amongst patients with CF and their
families. Annual screening for CFRD should be seen as a chance for
education and preparation for patients and families. Health care
providers can best assist in the acceptance of the diagnosis of CFRD
and its prescribed intervention by understanding that patients and
families must incorporate CFRD into their existing routines.
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Supplement: Interview questions
1. Tell me about when you were diagnosed with CFRD and what that was like for you and your family.
Did you know anything about CFRD before you were diagnosed?
What thoughts and feelings did you have when you found out?
How did your mom/dad/child react?
2. When you were diagnosed with CFRD, did you receive all of the information you needed about it?
What did the doctors or nurses tell you about CFRD?
What questions did you have for your parents and/or the doctors and nurses?
Is there anything you wish had gone differently?
3. How did the diagnosis of CFRD affect your daily life?
Is it difﬁcult to take care of CFRD on top of your/your child’s CF regimen?
What gets in the way of taking care of your/your child’s CF or CFRD?
What makes it easier to take care of your/your child’s CF or CFRD?
What is the hardest part of taking care of your/your child’s CF or CFRD?
4. Do you ever have symptoms of high or low blood sugar?
Does it worry you?
Do you tell your mom/dad about it?/Does your child tell you when he/she has symptoms?
Is it difﬁcult to keep your blood sugars in control?
5. What advice would you give to other kids/adults/parents who just found out they had CFRD?
6. What advice would you give to doctors and nurses who take care of kids and teenagers with CFRD?
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